• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算筛选天然和类天然化合物,以鉴定新型 sigma-2 受体配体。

Computational screening of natural and natural-like compounds to identify novel ligands for sigma-2 receptor.

机构信息

Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University , Al-Kharj, Saudi Arabia.

Department of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University , Al-Kharj, Saudi Arabia.

出版信息

SAR QSAR Environ Res. 2020 Nov;31(11):837-856. doi: 10.1080/1062936X.2020.1819870.

DOI:10.1080/1062936X.2020.1819870
PMID:33100033
Abstract

Sigma-2 (σ) receptor is a transmembrane protein shown to be linked with neurodegenerative diseases and cancer development. Thus, it emerges as a potential biological target for the advancement of anticancer and anti-Alzheimer's agents. The current study was aimed to identify potential σ receptor ligands using integrated computational approaches including homology modelling, combined pharmacophore- and docking-based virtual screening, and molecular dynamics (MD) simulation. Pharmacophore-based screening was conducted against a database composed of 20,523 small natural and natural-like products. In total, 1200 structures were found to satisfy the required pharmacophore features and were then exposed to docking-based screening against the generated homology model of σ receptor. On the basis of the pharmacophore fit scores, docking scores, and mechanism of binding interaction, 20 potential hits were retained. Five promising candidates were selected (SR84, SR823, SR300, SR413, and SR530) on the basis of their binding score and interaction. Further, in silico ADMET profiling of these compounds showed that the selected compounds possess favourable ADME properties with low toxicity risk. The mechanism of interaction of these compounds with σ receptor as well as their binding stability were characterized by MD simulation.

摘要

Sigma-2(σ)受体是一种跨膜蛋白,与神经退行性疾病和癌症的发展有关。因此,它成为开发抗癌和抗阿尔茨海默病药物的潜在生物靶点。本研究旨在使用包括同源建模、基于药效团和对接的虚拟筛选以及分子动力学(MD)模拟在内的综合计算方法来鉴定潜在的σ受体配体。基于药效团的筛选针对由 20523 种小分子天然产物和类似天然产物组成的数据库进行。总共发现了 1200 种结构满足所需药效团特征,然后针对生成的σ受体同源模型进行对接筛选。基于药效团拟合分数、对接分数和结合相互作用机制,保留了 20 个潜在的命中化合物。基于它们的结合分数和相互作用,选择了 5 种有前途的候选化合物(SR84、SR823、SR300、SR413 和 SR530)。进一步,这些化合物的计算机 ADMET 分析表明,所选化合物具有良好的 ADME 特性和低毒性风险。通过 MD 模拟研究了这些化合物与σ受体的相互作用机制及其结合稳定性。

相似文献

1
Computational screening of natural and natural-like compounds to identify novel ligands for sigma-2 receptor.计算筛选天然和类天然化合物,以鉴定新型 sigma-2 受体配体。
SAR QSAR Environ Res. 2020 Nov;31(11):837-856. doi: 10.1080/1062936X.2020.1819870.
2
Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.基于药效团的结构见解,通过计算机辅助筛选,鉴定人源 Toll 样受体 4-髓样分化因子 2(hTLR4-MD-2)复合物抑制剂。
J Biomol Struct Dyn. 2019 May;37(8):1968-1991. doi: 10.1080/07391102.2018.1474804. Epub 2018 May 29.
3
Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7.基于药效团的虚拟筛选方法鉴定人 Toll 样受体 7 的有效天然调节化合物。
J Biomol Struct Dyn. 2019 Nov;37(18):4721-4736. doi: 10.1080/07391102.2018.1559098. Epub 2019 Jan 21.
4
Identification of novel inhibitors for TNFα, TNFR1 and TNFα-TNFR1 complex using pharmacophore-based approaches.基于药效基团的方法鉴定新型 TNFα、TNFR1 及 TNFα-TNFR1 复合物抑制剂。
J Transl Med. 2019 Jul 2;17(1):215. doi: 10.1186/s12967-019-1965-5.
5
Pharmacophore and docking-based sequential virtual screening for the identification of novel Sigma 1 receptor ligands.基于药效团和对接的序列虚拟筛选以鉴定新型 Sigma 1 受体配体。
Bioinformation. 2019 Sep 10;15(8):586-595. doi: 10.6026/97320630015586. eCollection 2019.
6
Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.通过药效团、基于原子的定量构效关系、对接和分子动力学模拟对长春花结构域微管蛋白结合剂进行结构研究。
Comb Chem High Throughput Screen. 2017;20(8):682-695. doi: 10.2174/1386207320666170509151253.
7
Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, ADMET, and Molecular Dynamics (MD) Simulation of Potential Inhibitors of PD-L1 from the Library of Marine Natural Products.基于结构的药效团模型构建、虚拟筛选、分子对接、PD-L1 抑制剂的 ADMET 预测和分子动力学(MD)模拟研究:来自海洋天然产物库的潜在抑制剂。
Mar Drugs. 2021 Dec 25;20(1):29. doi: 10.3390/md20010029.
8
Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.通过多电子药效团、基于配体的药效团、分子对接和密度泛函理论方法鉴定选择性 MMP-9 抑制剂。
J Biomol Struct Dyn. 2019 Mar;37(4):944-965. doi: 10.1080/07391102.2018.1444510. Epub 2018 Mar 9.
9
Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.通过基于药效团的设计、3D-QSAR 和针对阿尔茨海默病的分子动力学模拟来鉴定潜在的蛋白激酶 C 抑制剂。
J Biomol Struct Dyn. 2018 Nov;36(15):4029-4044. doi: 10.1080/07391102.2017.1406824. Epub 2017 Dec 13.
10
On the value of homology models for virtual screening: discovering hCXCR3 antagonists by pharmacophore-based and structure-based approaches.同源模建在虚拟筛选中的价值:基于药效团和结构的方法发现 hCXCR3 拮抗剂。
J Chem Inf Model. 2012 May 25;52(5):1356-66. doi: 10.1021/ci300067q. Epub 2012 May 8.

引用本文的文献

1
Recent Advances in the Development of Sigma Receptor (Radio)Ligands and Their Application in Tumors.σ受体(放射性)配体的开发进展及其在肿瘤中的应用
ACS Pharmacol Transl Sci. 2025 Mar 7;8(4):951-977. doi: 10.1021/acsptsci.4c00711. eCollection 2025 Apr 11.
2
Recent advances in the area of plant-based anti-cancer drug discovery using computational approaches.利用计算方法在植物源抗癌药物发现领域的最新进展。
Mol Divers. 2024 Apr;28(2):901-925. doi: 10.1007/s11030-022-10590-7. Epub 2023 Jan 21.
3
Adamantane-derived scaffolds targeting the sigma-2 receptor; an and study.
靶向σ-2受体的金刚烷衍生支架;一项[具体研究内容缺失]研究。
Saudi Pharm J. 2021 Oct;29(10):1166-1172. doi: 10.1016/j.jsps.2021.08.016. Epub 2021 Aug 29.
4
Propellanes as Rigid Scaffolds for the Stereodefined Attachment of σ-Pharmacophoric Structural Elements to Achieve σ Affinity.作为用于立体定向连接σ-药效团结构元件以实现σ亲和力的刚性支架的螺桨烷。
Int J Mol Sci. 2021 May 26;22(11):5685. doi: 10.3390/ijms22115685.